Current Appointments & Affiliations
Medical Assistant Professor in the Department of Medicine
·
2025 - Present
Medicine, Medical Oncology,
Medicine
Member of the Duke Cancer Institute
·
2023 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment.
Journal Article JTO Clin Res Rep · September 2023 INTRODUCTION: SCLC is an aggressive malignancy with poor outcome. Most patients have disease recurrence despite treatments with multiple modalities. Subtyping of SCLC has been proposed recently, and novel agents targeting specific subtypes are actively bei ... Full text Link to item CiteRecent Grants
A Phase 2, Randomized, Blinded, Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab versus Placebo, in Combination with Pembrolizumab, Pemetrexed, and Carboplatin, in First-Line Treatment of Participants with Metastatic Non-S
Clinical TrialPrincipal Investigator · Awarded by CatalYm GmbH · 2026 - 2031View All Grants
Education
University of Puerto Rico, School of Medicine ·
2015
M.D.